<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0037">
 <label>37</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Abd El-Karim</surname>
    <given-names>SS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Syam</surname>
    <given-names>YM</given-names>
   </name>, 
   <name name-style="western">
    <surname>El Kerdawy</surname>
    <given-names>AM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Abdelghany</surname>
    <given-names>TM.</given-names>
   </name>
  </person-group>
  <article-title>New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: synthesis, CDK2 inhibition, QSAR and molecular docking studies</article-title>. 
  <source>Bioorg Chem</source>
  <year>2019</year>;
  <volume>86</volume>:
  <fpage>80</fpage>â€“
  <lpage>96</lpage>.
  <pub-id pub-id-type="pmid">30685646</pub-id>
 </mixed-citation>
</ref>
